Novavax, Inc.NVAXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank90
5Y CAGR+81.2%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+81.2%/yr
Long-term compound
Percentile
P90
Near historical high
vs 5Y Ago
19.6x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 111.81% |
| Q3 2025 | -268.47% |
| Q2 2025 | -79.50% |
| Q1 2025 | 493.28% |
| Q4 2024 | 2.19% |
| Q3 2024 | -183.24% |
| Q2 2024 | 216.05% |
| Q1 2024 | 24.43% |
| Q4 2023 | -46.12% |
| Q3 2023 | -326.54% |
| Q2 2023 | 117.73% |
| Q1 2023 | -28.25% |
| Q4 2022 | -91.75% |
| Q3 2022 | 73.66% |
| Q2 2022 | -330.76% |
| Q1 2022 | 125.37% |
| Q4 2021 | -168.59% |
| Q3 2021 | 11.19% |
| Q2 2021 | -65.76% |
| Q1 2021 | -14.10% |
| Q4 2020 | 5.72% |
| Q3 2020 | -1039.03% |
| Q2 2020 | 25.64% |
| Q1 2020 | 20.23% |
| Q4 2019 | -91.53% |
| Q3 2019 | 59.13% |
| Q2 2019 | 8.84% |
| Q1 2019 | 13.52% |
| Q4 2018 | -11.01% |
| Q3 2018 | 0.22% |
| Q2 2018 | 3.49% |
| Q1 2018 | 8.94% |
| Q4 2017 | -14.79% |
| Q3 2017 | -0.38% |
| Q2 2017 | -1.58% |
| Q1 2017 | 24.46% |
| Q4 2016 | 14.63% |
| Q3 2016 | 17.24% |
| Q2 2016 | -1.64% |
| Q1 2016 | 4.61% |